Reddoch James F.
CIK 0001814872
EVP & Chief Scientific Officer
Filings
3
Latest Jun 10, 2022
Issuers covered
1
Showing
3 of 3
Page 1
Track record
3 of 3 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 3 | 0% | -2.7% | -3.5% | -0.8% | -3.8% |
| 90 days | 3 | 0% | -6.3% | -5.8% | -1.0% | -12.2% |
| 180 days | 3 | 0% | -4.5% | -4.0% | -3.7% | -5.8% |
| 365 days | 3 | 100% | +17.8% | +16.8% | +21.2% | +15.3% |
Issuers
Companies where Reddoch James F. has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| RPRX | Royalty Pharma PLC | 3 | Jun 10, 2022 |
All filings
3 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|